Embecta Corp.
General ticker "EMBC" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $812.8M (TTM average)
Embecta Corp. follows the US Stock Market performance with the rate: 21.9%.
Estimated limits based on current volatility of 1.9%: low 12.45$, high 12.90$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-12-05, amount 0.15$ (Y4.84%)
- Total employees count: 2100 (-4.5%) as of 2024
- US accounted for 54.1% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Supply chain disruptions, Cybersecurity threats, Pandemic risks, Dependence on key products, Geopolitical risks
- Price in estimated range
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [11.64$, 20.30$]
- 2025-09-30 to 2026-09-30 estimated range: [11.75$, 20.49$]
Short-term EMBC quotes
Long-term EMBC plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $1,129.50MM | $1,120.80MM | $1,123.10MM |
| Operating Expenses | $819.90MM | $899.30MM | $956.30MM |
| Operating Income | $309.60MM | $221.50MM | $166.80MM |
| Non-Operating Income | $-53.00MM | $-115.80MM | $-122.60MM |
| Interest Expense | $46.20MM | $107.00MM | $112.30MM |
| R&D Expense | $66.90MM | $85.20MM | $78.80MM |
| Income(Loss) | $256.60MM | $105.70MM | $44.20MM |
| Taxes | $33.00MM | $35.30MM | $-34.10MM |
| Profit(Loss)* | $223.60MM | $70.40MM | $78.30MM |
| Stockholders Equity | $-891.40MM | $-821.70MM | $-738.30MM |
| Inventory | $122.80MM | $152.10MM | $171.50MM |
| Assets | $1,086.40MM | $1,214.40MM | $1,285.30MM |
| Operating Cash Flow | $412.20MM | $67.70MM | $35.70MM |
| Capital expenditure | $24.00MM | $26.50MM | $15.80MM |
| Investing Cash Flow | $-24.00MM | $-26.50MM | $-15.80MM |
| Financing Cash Flow | $-48.00MM | $-48.70MM | $-73.40MM |
| Earnings Per Share** | $3.92 | $1.23 | $1.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.